Výsledky vyhledávání - Gurwith, Marc
- Zobrazuji výsledky 1 - 20 z 42
- Přejít na další stránku
-
1
-
2
-
3
-
4
-
5
-
6
AIDSVAX Immunization Induces HIV-specific CD8+ T-cell Responses in High-risk, HIV-negative Volunteers Who Subsequently Acquire HIV Infection Autor Jones, Norman G, DeCamp, Allan, Gilbert, Peter, Peterson, Michael L, Gurwith, Marc, Cao, Huyen
Vydáno 2008Text -
7
Age, Race/Ethnicity, and Behavioral Risk Factors Associated with Per-Contact Risk of HIV Infection Among Men Who Have Sex with Men in the United States Autor Scott, Hyman M., Vittinghoff, Eric, Irvin, Risha, Sachdev, Darpun, Liu, Albert, Gurwith, Marc, Buchbinder, Susan P
Vydáno 2014Text -
8
Safety and Immunogenicity of Single-Dose Live Oral Cholera Vaccine Strain CVD 103-HgR, Prepared from New Master and Working Cell Banks Autor Chen, Wilbur H., Greenberg, Richard N., Pasetti, Marcela F., Livio, Sofie, Lock, Michael, Gurwith, Marc, Levine, Myron M.
Vydáno 2014Text -
9
-
10
The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety Autor Black, Steven B., Law, Barbara, Chen, Robert T., Dekker, Cornelia L., Sturkenboom, Miriam, Huang, Wan-Ting, Gurwith, Marc, Poland, Greg
Vydáno 2021Text -
11
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virus Autor Hernandez, Libia Milena, Sumathy, K., Sahastrabuddhe, Sushant, Excler, Jean-Louis, Kochhar, Sonali, Smith, Emily R., Gurwith, Marc, Chen, Robert T.
Vydáno 2022Text -
12
Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization Autor Khurana, Surender, Coyle, Elizabeth M., Manischewitz, Jody, King, Lisa R., Ishioka, Glenn, Alexander, Jeff, Smith, Jon, Gurwith, Marc, Golding, Hana
Vydáno 2015Text -
13
Treatment of Invasive Fungal Infections in Renally Impaired Patients with Amphotericin B Colloidal Dispersion Autor Anaissie, Elias J., Mattiuzzi, Gloria N., Miller, Carole B., Noskin, Gary A., Gurwith, Marc J., Mamelok, Richard D., Pietrelli, Larry A.
Vydáno 1998Text -
14
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273) Autor Leav, Brett, Straus, Walter, White, Phil, Leav, Alison, Gaines, Tashawnee, Maggiacomo, Grace, Kim, Denny, Smith, Emily R., Gurwith, Marc, Chen, Robert T.
Vydáno 2022Text -
15
Live Adenovirus Type 4 Recombinants Induce Durable Neutralizing Antibody Responses to Influenza H5 with High Levels of Somatic Hypermutation in Humans Autor Huang, Jinghe, Kang, Byong, Wheatley, Adam, Narpala, Sandeep, Mcdermott, Adrian, Poole, April, Bailer, Robert, Koup, Richard, Migueles, Stephen, Gurwith, Marc, Connors, Mark
Vydáno 2014Text -
16
Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment Autor Folegatti, Pedro M, Jenkin, Daniel, Morris, Susan, Gilbert, Sarah, Kim, Denny, Robertson, James S., Smith, Emily R., Martin, Emalee, Gurwith, Marc, Chen, Robert T.
Vydáno 2022Text -
17
Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study Autor Gurwith, Marc, Lock, Michael, Taylor, Eve M, Ishioka, Glenn, Alexander, Jeff, Mayall, Tim, Ervin, John E, Greenberg, Richard N, Strout, Cynthia, Treanor, John J, Webby, Richard, Wright, Peter F
Vydáno 2013Text -
18
Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines Autor Kochhar, Sonali, Excler, Jean-Louis, Bok, Karin, Gurwith, Marc, McNeil, Michael M., Seligman, Stephen J., Khuri-Bulos, Najwa, Klug, Bettina, Laderoute, Marian, Robertson, James S., Singh, Vidisha, Chen, Robert T.
Vydáno 2019Text -
19
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines Autor Condit, Richard C, Kim, Denny, Robertson, James S., Excler, Jean-Louis, Gurwith, Marc, Monath, Thomas P., Pavlakis, George, Fast, Patricia E., Smith, Jonathan, Smith, Emily R., Chen, Robert T., Kochhar, Sonali
Vydáno 2020Text -
20
Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge Autor Espinosa, Diego, Mendy, Jason, Manayani, Darly, Vang, Lo, Wang, Chunling, Richard, Tiffany, Guenther, Ben, Aruri, Jayavani, Avanzini, Jenny, Garduno, Fermin, Farness, Peggy, Gurwith, Marc, Smith, Jon, Harris, Eva, Alexander, Jeff
Vydáno 2017Text